Adding Phosphorus to Osteoporosis Drug Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
OsteoporosisOsteopenia
Interventions
DRUG

Calcium carbonate

Participants will receive teriparatide and vitamin D during the course of the 12-month study. They will also receive calcium carbonate.

DRUG

Calcium Phosphate

Participants will receive teriparatide and vitamin D during the course of the 12-month study. They will also receive calcium phosphate.

Trial Locations (1)

68131

Creighton University Medical Center, Omaha

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

collaborator

Office of Dietary Supplements (ODS)

NIH

lead

Creighton University

OTHER

NCT00074711 - Adding Phosphorus to Osteoporosis Drug Treatment | Biotech Hunter | Biotech Hunter